key: cord-0945633-66rnkbyd
authors: R T Romão, Pedro; Teixeira, Paula C; Schipper, Lucas; da Silva, Igor; Santana Filho, Paulo; Carlos Rodrigues Júnior, Luiz; Peres, Alessandra; Gonçalves da Fonseca, Simone; Chagas Monteiro, Marta; Lira, Fabio S; Andrey Cipriani Frade, Marco; Comerlato, Juliana; Baldisserotto Comerlato, Carolina; Hayashi Sant'Anna, Fernando; Bessel, Marina; Monteiro Abreu, Celina; Wendland, Eliana M; Dorneles, Gilson P
title: Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection
date: 2022-03-15
journal: Int Immunopharmacol
DOI: 10.1016/j.intimp.2022.108697
sha: b7a66a6321f33823a229d7ff1ecd89e468be5eb1
doc_id: 945633
cord_uid: 66rnkbyd

Monocytes play a major role in the initial innate immune response to SARS-CoV-2. Although viral load may correlate with several clinical outcomes in COVID-19, much less is known regarding their impact on innate immune phenotype. We evaluated the monocyte phenotype and mitochondrial function in severe COVID-19 patients (n=22) with different viral burden (determined by the median of viral load of the patients) at hospital admission. Severe COVID-19 patients presented lower frequency of CD14+CD16- classical monocytes and CD39 expression on CD14+ monocytes, and higher frequency of CD14+CD16+ intermediate and CD14-CD16+ nonclassical monocytes as compared to healthy controls independently of viral load. COVID-19 patients with high viral load exhibited increased GM-CSF, PGE-2 and lower IFN-α as compared to severe COVID-19 patients with low viral load (p<0.05). CD14+ monocytes of COVID-19 patients with high viral load presented higher expression of PD-1 but lower HLA-DR on the cell surface than severe COVID-19 patients with low viral load. All COVID-19 patients presented decreased monocyte mitochondria membrane polarization, but high SARS-CoV-2 viral load was associated with increased mitochondrial reactive oxygen species. In this sense, higher viral load induces mitochondrial reactive oxygen species generation associated with exhaustion profile in CD14+ monocytes of severe COVID-19 patients. Altogether, these data shed light on new pathological mechanisms involving SARS-CoV-2 viral load on monocyte activation and mitochondrial function, which were associated with COVID-19 severity.

The coronavirus disease 2019 pandemic caused by infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been rapidly spreading worldwide and afflicted millions following first reports at the end of 2019 (1) . Disease mortality (2% of the cases) is primarily caused by severe pneumonia and acute respiratory distress syndrome, whereas a significant proportion of patients is asymptomatic (20%) or develop mild COVID-19 symptomatic condition. Several risk factors, including age, sex, body mass index, and the presence of chronic diseases, are associated with COVID-19 severity and mortality (2) . More recently, some studies demonstrated that the high SARS-CoV-2 viral load was an independent predictor of mortality in large hospital cohorts (2) (3) (4) . Moreover, a higher prevalence of detectable SARS-CoV-2 plasma viral load is associated with worse respiratory disease severity, lower lymphocyte counts, and hypercytokinemia (4) .

SARS-CoV-2 possesses the ability to evade the innate immune defenses and to promote dysfunction and exacerbated inflammatory responses that are linked to the severity of acute infection. Increased viral load was previously (5) linked to hypercytokinemia, endothelial dysfunction, and coagulation activation, suggesting that RNA viremia may directly impact the innate immune response during the first days of infection. Although alterations in the myeloid cell phenotype and function was previously associated with severe COVID-19 (6, 7) , the association with viral load remains poor studied.

Monocytes play a key role in the initial immune response against several viruses and acquire an intermediate or nonclassical CD16+ phenotype during SARS-CoV-2 infection, and this response against virus request an adequate available energy source, principally in the mitochondrial function, to leads an adequate antiviral response without exacerbation of inflammation (8) . Once activated by sensing some pathogenassociated molecular pattern, monocytes activate the aerobic glycolysis axis through the Akt-mTOR-HIF-1α pathway to increase the energetic demand during the infection (9) .

Similarly, SARS-CoV-2 infection favors the HIF-1α/Glycolysis-Dependent Axis (10) associated with mitochondrial dysfunction (11) in monocytes that may be linked to the hyperinflammatory condition observed in severe COVID-19. On the other hand, monocytes from severe COVID-19 patients are phenotypically characterized by the downregulation of human leukocyte antigen DR isotype (HLA-DR) concomitant with the increased expression of chemokine receptors and pathogen recognition receptors (12) . Interestingly, a relationship between leukocyte mitochondrial oxygen consumption and HLA-DR expression was previously described in septic shock patients (13) , suggesting a key link between metabolic disturbance and changes in the activation patterns during acute infection or sepsis conditions. Moreover, we recently showed that blood factors, such as inflammatory cytokines and microbial products, found in the plasma of severe COVID-19 modulate monocyte phenotype to a dysfunctional hyperactivated profile (14) . Here, our study aimed to evaluate the role of viral load on innate cytokines and monocyte phenotype in severe COVID-19 patients.

We prospectively evaluated patients diagnosed with severe COVID-19 acute infection that were admitted to Hospital Moinhos de Vento and a sample of uninfected healthy individuals. The diagnosis of COVID-19 was confirmed by SARS-CoV-2 nucleic acid testing of nasal and pharyngeal throat swab specimens using real-time RT-PCR assay and the severity of COVID-19 was classified according to the WHO interim guidance (15) . This study was approved by the Moinhos de Vento Ethics Committee N 3977144 (Porto Alegre/Brazil) and informed consent was obtained from all participants. Flow cytometry experiments (described below) were conducted with fresh blood. The remaining blood was centrifuged (1500 g, 10 min), plasma was aliquoted and kept at -80 ºC until plasma analysis.

Nucleic acid extraction was carried out using 300 µL of each nasopharyngeal sample with the Maxwell® RSC Viral Total Nucleic Acid Purification Kit according to the manufacturer's instructions. Total nucleic acids were eluted in 50 µl of water.

SARS-CoV-2 viral load of the samples was determined using a real-time quantitative RT-PCR (RT-qPCR) assay for absolute quantification of the viral RdRp RNA previously developed by our group (17) . All samples were run in duplicates. Serial 10fold dilutions of known quantities of contrived RdRp transcripts (10² to 10⁹ molecules per reaction) were utilized by plate, as reference, for establishing the standard curve.

The plasma concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-alpha (IFN-α), prostaglandin E2 (PGE-2), tumor necrosis factor-alpha (TNF-α) (all from Invitrogen, ThermoFisher, USA) were quantified by enzyme-linked immunosorbent assay (ELISA) in microplate reader (EzReader, EUA). The detection limits of each cytokine were GM-CSF, 6 -750 pg/mL, IFN-α, 2 -300 pg/mL, TNF-α, 2-400 pg/mL; PGE-2, 39.1 -10.000 pg/mL.

Lipid peroxidation was measured through the thiobarbituric acid reactive substances (TBARS) in plasma following a previously described protocol (18) incubated with potassium persulphate (Sigma-Aldrich) to produce ABTS⋅+, a green/blue chromophore. The inhibition of ABTS⋅+ formation by antioxidants in the samples was expressed as Trolox equivalents, determined at 740mm using a calibration curve plotted with different amounts of Trolox (Sigma-Aldrich). Nitrite levels were determined by Griess method as previously described (19) .

Whole blood samples (100 µL) were incubated with monoclonal surface antibodies (all anti-human) at 4ºC for 20 min in accordance with the following combination: a) FITC- 

The mitochondrial membrane potential (ΔΨm) was quantified according to a method previously described (20) , using the fluorescent dye rhodamine 123 (Rh 123, Sigma-

Red (Invitrogen, ThermoFisher, USA). Analyses were performed by using CELLQuest Pro Software (BD Bioscience) on a FACSCalibur flow cytometer (BD Bioscience)

Normality of data was checked by Kolmogorov-Smirnov, and the values were presented as mean ± standard deviation (SD). A one-way ANOVA followed by Bonferroni's post-hoc for multiple comparisons was used to verify between-groups differences. 

The characteristics of severe COVID-19 patients and controls were presented in Table   1 . COVID-19 patients were assigned to low or high viral load in accordance with the median of SARS-CoV-2 log copies/mL. The mean viral load of severe COVID-19 patients was 3.57 ± 1.57 log copies/mL, and high viral load group presented superior SARS-CoV-2 copies than low viral load group as expected (4.8 ± 0.9 vs. 2.2 ± 0.8 log copies/mL, p=0.001). Severe COVID-19 patients with high viral load presented low time interval between onset of symptoms and blood collection (7.8 ± 3.4 vs. 11.9 ± 3.2 days, p=0.01). The low and high COVID-19 viral load groups also differed in the number of days from symptoms onset and blood sample collection (p=0.01), heart rate (p=0.02), the prevalence of sore throat symptom (p=0.02), and type 2 diabetes mellitus (p=0.02). Quantitative data presented as mean ± standard deviation. Between groups comparison through one way ANOVA (p<0.05). BMI, body mass index; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate. Qualitative data presented as relative frequency. Between groups comparison through Qui-square test (p<0.05). Statistical analysis was conducted through one-way ANOVA followed by Bonferroni's post-hoc (p<0.05).

The expression of CD39, CD73, PD-1 and HLA-DR were analyzed on the cell surface of CD14+ monocytes. Monocytes of healthy controls presented higher CD39 expression 

The variable "days of symptoms onset" was significantly positively correlated to peripheral (Figure 3) . 

Here, we report that monocytes from patients with severe Host immune responses to SARS-CoV-2 are directly dependent of viral load and infection course (26) . Interestingly, the days from symptom onset to sample collection in our cohort were lower in higher viral load group suggesting that symptomatic phase may occur early in these patients. However, viral load was not determinant to change the peripheral frequency of monocyte subsets and T cells. A methodological limitation of our study in the context of T cell phenotype was that we gated the CD4+ and CD8+ cells without the use of CD3 staining. In fact, CD4 is also expressed in a small frequency of myeloid innate cells (i.e., monocytes and dendritic cells) and in B cells, while CD8 can also be identified on NK cells and dendritic cells (27) . Although there is usually only a small proportion of others immune cells, this aspect should be considered in future studies. In addition, we were unable to differentiate CD14-monocyte subsets to evaluate the expression of CD39, CD73, PD-1 and HLA-DR due to methodological aspects. Furthermore, viral load was not determinant to the diminished CD39 expression in CD14+ monocytes of severe COVID-19 patients.

By regulating purine concentrations in the extracellular space, the CD39/CD73 ectonucleotidase axis is important for fine-tuning innate differentiation and activity (28) . In this sense, the lower CD39 expression without changes in CD73 found in our study may indicate impaired capacity to metabolize extracellular ATP by monocytes which leads to the production of proinflammatory cytokines (29) . Interestingly, we (28) recently found an imbalance in CD39/CD73 axis in CD4+ and CD8+ T cells linked to alterations in adenine-based purine molecules and increased exhaustion markers in CD8+ T cells.

Here, we showed for the first time that viral load was associated with higher PD The upregulation of PD-1 expression in monocytes of COVID-19 patients was previously described, and was accompanied by alterations in metabolic response, such as reduced oxidative phosphorylation, reduced extracellular acidification rate and altered mitochondrial ultrastructure (11) . Here, we confirmed these results by changes in mitochondrial membrane polarization. In fact, changes in mitochondrial membrane potential generated by proton pumps (Complexes I, III and IV) in inner mitochondrial membrane alters the process of energy storage during oxidative phosphorylation (38) .

Furthermore, we found increased mitochondrial ROS generation by monocytes of severe COVID-19 patients. Previous studies described that macrophages produce higher amounts of mitochondrial ROS for the killing of intracellular pathogens (39) . On the other hand, SARS-CoV-2 infection triggers mitochondrial ROS production which stabilize hypoxia-inducible factor-alpha1 (HIF-1α) and promotes glycolysis, these metabolic changes directly inhibit T cell response and aggravates the hypercytokinemia condition during severe COVID-19 (10, 40) . Compromised mitochondria respiration and increased ROS production are features of exhausted monocytes presenting low HLA-DR expression in septic conditions (13, 41) , indicating that phenotypic changes in monocytes are accompanied by metabolic disturbances. The accumulation of dysfunctional mitochondria and increased ROS generation could lead to defective immune response, not only against SARS-CoV-2 but also increasing susceptibility to secondary infections, and the interaction between PD-1 signaling and mitochondrial dysfunction leading to increased ROS generation and tissue damage (42) . In this sense, a crossover between mitochondrial ROS production and increased viral replication may occur in severe COVID-19 patients with higher viral load, perpetuating the inflammatory response and monocyte dysfunction.

In conclusion, we showed that high SARS-CoV-2 viral load alters the systemic inflammatory profile, the bioactive lipid mediators and the redox state of severe COVID-19 patients at hospital admission. Elevated viral load was associated with alterations in activation and inhibitory immune checkpoints and mitochondrial ROS production by CD14+ monocytes. Furthermore, increased mitochondrial ROS and higher PD-1 expression in CD14+ monocytes of COVID-19 patients with high viral load may denote the premature exhaustion profile of innate immune cells through dysfunctional metabolic response induced by the infection. These data may explain why the higher viral load may lead to the severity of clinical outcomes during acute infection through alterations in immune response and redox state of the host.

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease

SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic

SARS-CoV-2 viral load predicts COVID-19 mortality

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. Front Immunol

The role of glucose homeostasis on immune function in response to exercise: The impact of low or higher energetic conditions

mTOR-and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia

Monocytes and Macrophages in COVID-19. Front Immunol

Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis

Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients

WHO COVID-19 Case definition

Interim Guidelines for Clinical Specimens for COVID-19 | CDC

Memórias do Instituto Oswaldo Cruz -0237_Open-source real-time quantitative RT-PCR based in a RNA standard for assessment of SARSCoV-2 viral load

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite

Assay for apoptosis using the mitochondrial probes, Rhodamine123 and 10-N-nonyl acridine orange

SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection

Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease

Prostaglandin E2 Inhibits IFN-α Secretion and Th1 Costimulation by Human Plasmacytoid Dendritic Cells via E-Prostanoid 2 and E-Prostanoid 4 Receptor Engagement

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

CD4 and CD8: an inside-out coreceptor model for innate immune cells

Alterations in CD39/CD73 Axis of T cells associated with COVID-19 severity

NTPDase1 governs P2X7-dependent functions in murine macrophages

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe

Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns

Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19

Virus-induced senescence is a driver and therapeutic target in COVID-19

Analysis of PD-1 expression in the monocyte subsets from non-septic and septic preterm neonates

Monocyte Programmed Death Ligand-1, A Predicator for 28-Day Mortality in Septic Patients

Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression

A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: Implications for their use as bioenergetic biomarkers

Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages

HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19

Development of Exhausted Memory Monocytes and Underlying Mechanisms. Front Immunol

Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

We are grateful to the Brazilian agencies Coordenação de Aperfeiçoamento de Pessoal